Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation

Completed

Conditions studied: Atrial Fibrillation

In brief

This is a prospective, case-control study that seeks to learn about the role of genetics in early onset atrial fibrillation (AF) and if genetic testing can be used to improve how the investigators treat atrial fibrillation. The study will enroll 225 participants. Eligible participants will have undergone sequencing for arrhythmia and cardiomyopathy (CM) genes. Based on those results, participants will be recruited for an outpatient research visit with testing that includes cardiac MRI, rest/stress/signal-averaged ECGs, and cardiac monitoring. If an inherited arrhythmia/CM syndrome is diagnosed, guideline-directed changes to medical care will be recommended.

Key facts

Study ID
NCT05190679
Run by
Vanderbilt University Medical Center
People needed
155
Starts
2022-04-27
Expected to finish
2026-03-03
Last updated by the study team
2026-05-06

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.